Sonrotoclax

• Description:

  Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  890.1

• Molecular Formula:

  C49H59N7O7S

• Notes:

  Research use only, not for human use.

• Receptor:

  BCL

• CAS Number:

  2383086-06-2